# Dezima Pharma

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/dezima-pharma

- Industry: Biotechnology
- Headquarters: Naarden, Netherlands
- Website: www.dezimapharma.com
- Total disclosed funding: $13M
- Latest round: Series A (Feb 28, 2013)
- Investors on record: 3

## About

Founded in 2012 and based in Naarden, Netherlands, Dezima Pharma BV operates as a biotechnology company that develops novel drugs to treat cardiovascular disease related to dyslipidemia.

## Funding rounds

- Series A, Feb 28, 2013, $13M — Forbion, BioGeneration Ventures, New Science Ventures
- Seed, Jun 1, 2012 — Forbion, BioGeneration Ventures

## Investors

- Forbion (https://capitalatlas.ai/funds/forbion) — Seed, Series A
- BioGeneration Ventures (https://capitalatlas.ai/funds/biogeneration-ventures) — Seed, Series A
- New Science Ventures (https://capitalatlas.ai/funds/new-science-ventures) — Series A